Stocks and InvestingStocks and Investing
Wed, September 9, 2015
Tue, September 8, 2015
Mon, September 7, 2015
Fri, September 4, 2015
Thu, September 3, 2015
Wed, September 2, 2015
Tue, September 1, 2015
Mon, August 31, 2015
Sat, August 29, 2015
Fri, August 28, 2015
Thu, August 27, 2015
Wed, August 26, 2015
Tue, August 25, 2015
Mon, August 24, 2015
Fri, August 21, 2015
Thu, August 20, 2015
Wed, August 19, 2015
Tue, August 18, 2015
Mon, August 17, 2015
Fri, August 14, 2015
Thu, August 13, 2015
Wed, August 12, 2015
Tue, August 11, 2015
Mon, August 10, 2015

Matt Miksic Initiated (ABT) at Buy with Increased Target to $55 on, Aug 10th, 2015


Published on 2024-10-25 09:40:44 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Initiated "Abbott Laboratories" (ABT) at Buy with Increased Target from $50 to $55 on, Aug 10th, 2015.

Matt has made no other calls on ABT in the last 4 months.



There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matt


  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $56 on, Thursday, July 23rd, 2015
  • Vijay Kumar of "Evercore ISI Group" Initiated at Strong Buy and Held Target at $54 on, Wednesday, May 27th, 2015